IMMUNIC, INC. — Form D/A

IMMUNIC, INC. of NEW YORK, X1, a company, filed a Form D amendment with the SEC on 2012-11-07. The offering totals $86.1M, of which $86.1M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (56)

Showing 25 of 56 people.

NameRoleLocation
Phillip Michael CroxfordDirectorSan Diego, CA
Randolph Michael SteerDirectorSan Diego, CA
Terence WintersDirectorSan Diego, CA
Robert Michael AshleyExecutive OfficerSan Diego, CA
Duane Michael NashExecutive OfficerSan Diego, CA
Aron Michael SternExecutive OfficerSan Diego, CA
Terence WintersExecutive OfficerSan Diego, CA
Muneer A SatterDirectorChicago, IL
Patrick WalshExecutive OfficerNew York, NY
Andreas MuehlerExecutive OfficerNew York, NY
Barclay PhillipsDirectorNew York, NY
Inderpal SinghExecutive OfficerNew York, NY
Daniel VittDirectorNew York, NY
Daniel VittExecutive OfficerNew York, NY
Duane NashDirectorNew York, NY
Tamar HowsonDirectorNew York, NY
Jorg NeermannDirectorNew York, NY
Richard RudickDirectorNew York, NY
Glenn WhaleyExecutive OfficerNew York, NY
Maria TornsenDirectorNew York, NY
Hella KohlhofExecutive OfficerNew York, NY
Vincent OssipowDirectorNew York, NY
Monika Maria TornsenDirectorNew York, NY
Jorg NeermanDirectorNew York, NY
Inderpal Maria SinghExecutive OfficerNew York, NY

Other filings by this issuer (23)

Showing 15 of 23 filings.

FiledFormOfferingSold
2026-03-04D$200.0M$200.0M
2024-01-19D$240.0M$80.0M
2022-10-18D$60.0M$60.0M
2014-03-07D/A$13.9M$13.9M
2014-02-04D$12.0M$12.0M
2014-01-31D/A$32.0M$32.0M
2013-06-24D/A$22.5M$22.5M
2013-03-14D$14.3M$14.3M
2012-10-09D$76.1M$76.1M
2012-06-22D$2.5M
2012-02-17D$1.5M$930K
2011-06-23D$56.9M$22.6M
2011-06-22D/A$16.3M$16.3M
2011-02-07D/A$14.0M
2011-01-04D/A$13.4M

More